⌘K

Login Start Free

Home/Filings/4/0001209191-15-050757

4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-15-050757

$TCRTCIK 0001107421operating

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 6:04 PM ET

Size

15.3 KB

Accession

0001209191-15-050757

Insider Transaction Report

Form 4

Period: 2015-06-03

ZIOPHARM ONCOLOGY INCZIOP

Vice Pres., Treasurer, & CAO

Transactions

Exercise/Conversion
Common Stock
2015-06-03$2.30/sh+27,500$63,250→ 27,500 total
Exercise/Conversion
Stock Option (right to buy)
2015-06-03−27,500→ 55,000 total
Exercise: $2.30Exp: 2023-06-27→ Common Stock (27,500 underlying)
Sale
Common Stock
2015-06-03$9.60/sh−26,666$255,994→ 0 total
Exercise/Conversion
Stock Option (right to buy)
2015-06-03−3,334→ 0 total
Exercise: $0.80Exp: 2019-02-06→ Common Stock (3,334 underlying)
Exercise/Conversion
Common Stock
2015-06-03$0.80/sh+3,334$2,667→ 3,334 total
Sale
Common Stock
2015-06-03$9.70/sh−3,334$32,340→ 0 total
Sale
Common Stock
2015-06-03$9.70/sh−27,500$266,750→ 0 total

Footnotes (2)

[F1]Fully vested.
[F2]27,500 shares vest on each of 6/27/2014, 6/27/2015 and 6/27/2016.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001107421

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 6:04 PM ET
Size: 15.3 KB

View on SEC.gov